Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Go back to Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.40 +0.05 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.35 | 52 Week High | $9.23 | |||
| Open | $9.45 | 52 Week Low | $1.16 | |||
| Day High | $9.69 | P/E | N/A | |||
| Day Low | $9.34 | EPS | $-0.30 | |||
| Volume | 2,718,492 | |||||
